Digital Lifestyle Intervention for Lung Cancer Survivors
QUALUCA
Effect of a Digital Lifestyle Intervention on Health-Related Quality of Life in Non-Small Cell Lung Cancer Survivors (QUALUCA): a Multicenter Randomized Controlled Trial
1 other identifier
interventional
88
1 country
4
Brief Summary
The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2023
CompletedFirst Posted
Study publicly available on registry
April 19, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedJanuary 30, 2025
January 1, 2025
2.3 years
April 6, 2023
January 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health-related quality of life (Scale-Global health status)
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) (2 items; 7-point Likert-type scale; the score ranges from 0 to 100; a high score for the global health status represents a high HRQoL)
Change from baseline to 3 months
Secondary Outcomes (11)
Health-related quality of life (5 functional scales, 9 symptom scales/items)
Change from baseline to 3 months
Lung cancer-specific health-related quality of life (10 symptom scales/items)
Change from baseline to 3 months
Body mass index [kg/m²]
Change from baseline to 3 months
Physical activity (self-reported)
Change from baseline to 3 months
Functional exercise capacity
Change from baseline to 3 months
- +6 more secondary outcomes
Other Outcomes (4)
Usability (intervention group only)
At 3 months follow-up (end of the intervention)
Acceptability, appropriateness, and feasibility (intervention group only)
At 3 months follow-up (end of the intervention)
Experiences and satisfaction with the digital lifestyle intervention (intervention group only)
At 3 months follow-up (end of the intervention)
- +1 more other outcomes
Study Arms (2)
Digital lifestyle intervention
EXPERIMENTALSelf-management mobile application covering physical activity, nutrition, and breathing/relaxation
Control
NO INTERVENTIONUsual care (study participation does not interfere with or change any other planned treatments)
Interventions
Participants assigned to the intervention group receive access to a lifestyle mobile application for three months after rehabilitation or treatment has finished. The digital program is target group-specific and includes personalization and interactive elements without face-to-face appointments during the intervention. One virtual appointment at the beginning of the intervention with the study staff ensures that participants familiarize themselves with the mobile application and that they are assigned to a suitable program level. The intervention is mainly based on the following behavior change technique (BCT) clusters: goals and planning, feedback and monitoring, shaping knowledge, and comparison of behavior.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Diagnosis of non-small cell lung cancer (NSCLC)
- Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals)
- Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24 weeks
- Knowledge of German to understand study material and assessments
- Access to a cell phone or tablet
- Written informed consent
You may not qualify if:
- Inability to provide informed consent
- Inability to participate in the intervention because of physical, cognitive, or safety reasons (judged by local investigators/responsible health professionals)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Klinik Barmelweid AG
Barmelweid, 5017, Switzerland
Zürcher RehaZentren | Klinik Davos
Davos, 7272, Switzerland
Berner Reha Zentrum AG
Heiligenschwendi, 3625, Switzerland
Zürcher RehaZentren | Klinik Wald
Wald, 8636, Switzerland
Related Publications (1)
Weber M, Raab AM, Schmitt KU, Busching G, Marcin T, Spielmanns M, Puhan MA, Frei A. Efficacy of a digital lifestyle intervention on health-related QUAlity of life in non-small cell LUng CAncer survivors following inpatient rehabilitation: protocol of the QUALUCA Swiss multicentre randomised controlled trial. BMJ Open. 2024 Mar 7;14(3):e081397. doi: 10.1136/bmjopen-2023-081397.
PMID: 38453202BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anja Frei, PhD
University of Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor
Study Record Dates
First Submitted
April 6, 2023
First Posted
April 19, 2023
Study Start
August 1, 2023
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
January 30, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
Pseudonymized data will be made available upon reasonable request after the main results have been published. The privacy of each subject and confidentiality of their information will be preserved in reports and publication of data.